Bristol Myers Squibb Co. (BMY)
61.48
-1.52
(-2.41%)
USD |
NYSE |
Oct 23, 16:00
61.49
+0.01
(+0.02%)
After-Hours: 20:00
Bristol Myers Squibb Price : 61.48 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 62.66 | 62.84 | 61.31 | 61.48 | 9.763M |
| Oct 22, 2026 | 61.46 | 63.59 | 61.04 | 63.00 | 15.17M |
| Oct 21, 2026 | 61.50 | 61.81 | 60.68 | 61.12 | 9.016M |
| Oct 20, 2026 | 59.93 | 61.82 | 59.83 | 61.68 | 11.91M |
| Oct 19, 2026 | 59.40 | 59.87 | 58.44 | 58.83 | 11.55M |
| Oct 16, 2026 | 61.10 | 61.43 | 59.54 | 59.75 | 13.77M |
| Oct 15, 2026 | 60.67 | 62.25 | 60.39 | 60.57 | 13.75M |
| Oct 14, 2026 | 56.81 | 59.38 | 56.58 | 59.28 | 14.05M |
| Oct 13, 2026 | 57.78 | 58.02 | 56.15 | 56.67 | 16.96M |
| Oct 12, 2026 | 60.11 | 60.68 | 56.72 | 57.58 | 22.57M |
| Oct 09, 2026 | 58.88 | 59.79 | 58.74 | 59.12 | 9.254M |
| Oct 08, 2026 | 59.10 | 59.94 | 58.73 | 59.58 | 13.07M |
| Oct 07, 2026 | 59.45 | 60.10 | 59.01 | 59.70 | 11.09M |
| Oct 06, 2026 | 58.94 | 59.60 | 58.64 | 59.59 | 9.886M |
| Oct 05, 2026 | 59.89 | 60.15 | 58.33 | 58.81 | 19.24M |
| Oct 02, 2026 | 60.66 | 61.24 | 60.24 | 61.15 | 9.936M |
| Oct 01, 2026 | 62.20 | 62.61 | 61.25 | 61.46 | 10.77M |
| Sep 30, 2026 | 63.28 | 64.13 | 62.40 | 62.40 | 15.87M |
| Sep 29, 2026 | 63.58 | 63.89 | 61.95 | 62.86 | 15.84M |
| Sep 28, 2026 | 62.77 | 63.93 | 62.30 | 63.88 | 14.02M |
| Sep 25, 2026 | 61.75 | 62.91 | 61.40 | 62.86 | 10.67M |
| Sep 24, 2026 | 61.40 | 61.59 | 60.60 | 61.50 | 14.90M |
| Sep 23, 2026 | 62.31 | 62.65 | 61.08 | 61.15 | 15.84M |
| Sep 22, 2026 | 62.73 | 63.08 | 62.03 | 62.25 | 15.24M |
| Sep 21, 2026 | 63.09 | 63.40 | 62.62 | 62.62 | 6.839M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 263.81 |
| Eli Lilly & Co. | 1273.46 |
| Merck & Co., Inc. | 145.27 |
| Pfizer Inc. | 30.03 |
| AstraZeneca PLC | 171.49 |
Price Related Metrics
| PE Ratio | 13.54 |
| PS Ratio | 2.554 |
| PEG Ratio | 0.1629 |
| Price to Book Value | 5.628 |
| Price to Free Cash Flow | 10.98 |
| Earnings Yield | 7.38% |
| Market Cap | 125.60B |
| PEGY Ratio | 0.1552 |
| Operating PE Ratio | 7.894 |
| Normalized PE Ratio | 10.01 |